Kyongtae Ty Bae
University of Pittsburgh
H-index: 84
North America-United States
Top articles of Kyongtae Ty Bae
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Risk severity model for pediatric autosomal dominant polycystic kidney disease using 3D ultrasound volumetry | Clinical Journal of the American Society of Nephrology | Luc Breysem Frederik De Keyzer Pieter Schellekens Angélique Dachy Stephanie De Rechter | 2023/5/1 |
Association of longitudinal urinary metabolic biomarkers with ADPKD severity and response to metformin in TAME-PKD clinical trial participants | Kidney International Reports | Kenneth R Hallows Kaleab Z Abebe Hui Li Biagio Saitta Andrew D Althouse | 2023/3/1 |
Generative AI in medical imaging: applications, challenges, and ethics | Journal of Medical Systems | Mohamad Koohi-Moghadam Kyongtae Ty Bae | 2023/8/31 |
Utility of new image-derived biomarkers for autosomal dominant polycystic kidney disease prognosis using automated instance cyst segmentation | Kidney international | Adriana V Gregory Fouad T Chebib Bhavya Poudyal Heather L Holmes SL Alan | 2023/8/1 |
The Resolution Rate of Pulmonary Embolism on CT Pulmonary Angiography: a Prospective Study | European Journal of Radiology | M Ak S Gumus A Aghayev CH Chang B Fu | 2022/10/1 |
A deep learning approach for automated segmentation of kidneys and exophytic cysts in individuals with autosomal dominant polycystic kidney disease | Journal of the American Society of Nephrology | Youngwoo Kim Cheng Tao Hyungchan Kim Geum-Yoon Oh Jeongbeom Ko | 2022/8/1 |
Volume progression and imaging classification of polycystic liver in early autosomal dominant polycystic kidney disease | Clinical Journal of the American Society of Nephrology | Kyongtae T Bae Cheng Tao Robert Feldman SL Alan Vicente E Torres | 2022/3/1 |
Method and system for monitoring a tissue parameter such as proteoglycan content by magnetic resonance imaging | 2021/7/27 | ||
Association of baseline urinary metabolic biomarkers with ADPKD severity in TAME-PKD clinical trial participants | Kidney360 | Kenneth R Hallows Andrew D Althouse Hui Li Biagio Saitta Kaleab Z Abebe | 2021/5/1 |
Prognostic value of fibroblast growth factor 23 in autosomal dominant polycystic kidney disease | Kidney International Reports | Mireille El Ters Pengcheng Lu Jonathan D Mahnken Jason R Stubbs Shiqin Zhang | 2021/4/1 |
Primary results of the randomized trial of metformin administration in polycystic kidney disease (TAME PKD) | Kidney international | Ronald D Perrone Kaleab Z Abebe Terry J Watnick Andrew D Althouse Kenneth R Hallows | 2021/9/1 |
Expanded imaging classification of autosomal dominant polycystic kidney disease | Journal of the American Society of Nephrology | Kyongtae T Bae Tiange Shi Cheng Tao SL Alan Vicente E Torres | 2020/7/1 |
Determination of contrast medium dose for hepatic CT enhancement with improved body size dependency using a non-linear analysis based on pharmacokinetic principles | Clinical Radiology | T Hibino K Ichikawa Y Fang S Ito H Kawashima | 2020/3/1 |
Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease | Kidney international | Katharina Hopp Emilie Cornec-Le Gall Sarah R Senum Iris BAW Te Paske Sonam Raj | 2020/2/1 |
Baseline characteristics and patient-reported outcomes of ADPKD patients in the multicenter TAME-PKD clinical trial | Kidney360 | Stephen L Seliger Terry Watnick Andrew D Althouse Ronald D Perrone Kaleab Z Abebe | 2020/12/1 |
The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD | JCI insight | Sravanthi Lavu Lisa E Vaughan Sarah R Senum Timothy L Kline Arlene B Chapman | 2020/8/8 |
